.jpg "Kuat Oshakbayev, 3202 photo")
deputy director for R&D&C
University Medical Center, Kazakhstan
Dear attendees and everyone,
We conducted a 6-week open pilot prospective clinical trial to evaluate the fast weight loss method on renal function, blood pressure, liver function, and inflammation, in treated patients with type two diabetes (T2D), Diabetic nephropathy (DN) with moderate renal failure, Hypertension (H), and Metabolic dysfunction-associated steatohepatitis (MASH).
The results of this study showed the beneficial role of the fast weight loss method in improving glycemic profiles, kidney and hepatic function parameters, blood pressure, lipids, and in improving of steatosis/fibrosis outcomes in patients with treated T2D+DN+H+MASH. The fast weight loss method allowed patients to stop taking medications.
Competing interests: Conflicts of interest were not declared by any author. All authors have contributed significantly, and that all authors are in agreement with the content of the manuscript.
Best respects,
Kuat Oshakbayev (MD, PhD, DMSc, professor), Altay Nabiyev (MD, PhD), et al.